fluoxetine has been researched along with lithium chloride in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (7.14) | 18.7374 |
1990's | 1 (7.14) | 18.2507 |
2000's | 3 (21.43) | 29.6817 |
2010's | 8 (57.14) | 24.3611 |
2020's | 1 (7.14) | 2.80 |
Authors | Studies |
---|---|
Lorden, JF; Nunn, WB | 1 |
Balogh, S; Hendricks, SE; Prendergast, MA; Yells, DP | 1 |
Alpert, J; Baer, L; Fava, M; Lagomasino, I; Nierenberg, A; Rosenbaum, JF; Sonawalla, S; Tedlow, J; Worthington, J | 1 |
Baldwin, RA; Caplan, R; Mazarati, A; Sankar, R; Shin, D; Siddarth, P | 1 |
Limebeer, CL; Litt, DE; Parker, LA | 1 |
Ahnert-Hilger, G; Budde, H; Heinz, A; Höltje, M; Lautenschlager, M; Priller, J; Scheuch, K | 1 |
Bliziotes, MM; Bogenschutz, ED; Bond, JL; Fuchs, RK; Grogg, JD; Hassett, SM; Hilles, EL; Rydberg, J; Smith, HD; Turner, CH; Warden, SJ | 1 |
Fitzgerald, PJ; Hefner, KR; Holmes, A; Ihne, JL | 1 |
Beurel, E; Jope, RS; Mines, MA; Song, L | 1 |
Calabrese, B; Halpain, S | 1 |
Bascuñana, P; de Cristóbal, J; Delgado, M; Fernández de la Rosa, R; García-García, L; Pozo, MA; Shiha, AA | 1 |
Abrial, E; Bétourné, A; Etiévant, A; Haddjeri, N; Lambás-Señas, L; Lucas, G; Scarna, H | 1 |
Hamada, T; Hiraiwa, H; Hirakawa, A; Ishiguro, N; Ito, M; Masuda, A; Miyamoto, K; Ohkawara, B; Ohno, K; Sakai, T | 1 |
Ascencio Gutierrez, V; Boersma, GJ; Carrillo, AA; Iñiguez, SD; Moran, TH; Tamashiro, KLK; Treesukosol, Y | 1 |
1 trial(s) available for fluoxetine and lithium chloride
Article | Year |
---|---|
Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine.
Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antimanic Agents; Chi-Square Distribution; Depressive Disorder, Major; Desipramine; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Fluoxetine; Humans; Lithium Chloride; Male; Middle Aged | 2002 |
13 other study(ies) available for fluoxetine and lithium chloride
Article | Year |
---|---|
Effects of central and peripheral pretreatment with fluoxetine in gustatory conditioning.
Topics: 5-Hydroxytryptophan; Animals; Chlorides; Conditioning, Classical; Dopamine; Fluoxetine; Lithium; Lithium Chloride; Male; Norepinephrine; Propylamines; Raphe Nuclei; Rats; Serotonin; Sucrose; Taste | 1982 |
Conditioned taste aversion induced by fluoxetine.
Topics: Animals; Avoidance Learning; Conditioning, Classical; Dose-Response Relationship, Drug; Drinking; Fluoxetine; Lithium Chloride; Male; Rats; Selective Serotonin Reuptake Inhibitors; Sucrose; Taste | 1996 |
Depression after status epilepticus: behavioural and biochemical deficits and effects of fluoxetine.
Topics: Animals; Behavior, Animal; Depression; Epilepsy, Temporal Lobe; Fluoxetine; Hippocampus; Lithium Chloride; Male; Models, Animal; Pilocarpine; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Status Epilepticus | 2008 |
Effect of 5-HT3 antagonists and a 5-HT(1A) agonist on fluoxetine-induced conditioned gaping reactions in rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antiemetics; Autoreceptors; Conditioning, Psychological; Dose-Response Relationship, Drug; Fluoxetine; Isoquinolines; Lithium Chloride; Male; Nausea; Ondansetron; Palonosetron; Quinuclidines; Rats; Rats, Sprague-Dawley; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT3 Receptor Antagonists | 2009 |
Lithium modulates tryptophan hydroxylase 2 gene expression and serotonin release in primary cultures of serotonergic raphe neurons.
Topics: Adjuvants, Immunologic; Analysis of Variance; Animals; Bacterial Proteins; Cells, Cultured; Dose-Response Relationship, Drug; Embryo, Mammalian; Fluoxetine; Gene Expression Regulation; L-Lactate Dehydrogenase; Lithium Chloride; Neurons; Potassium; Raphe Nuclei; Rats; Regression Analysis; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin; Streptolysins; Time Factors; Tritium; Tryptophan Hydroxylase | 2010 |
Psychotropic drugs have contrasting skeletal effects that are independent of their effects on physical activity levels.
Topics: Absorptiometry, Photon; Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antimanic Agents; Bone Density; Bone Remodeling; Compressive Strength; Desipramine; Enzyme-Linked Immunosorbent Assay; Female; Femur; Fluoxetine; Hindlimb Suspension; Lithium Chloride; Mice; Motor Activity; Random Allocation; Serotonin; Spine | 2010 |
Pharmacological modulation of stress-induced behavioral changes in the light/dark exploration test in male C57BL/6J mice.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Body Weight; Central Nervous System Stimulants; Chlordiazepoxide; Corticosterone; Disease Models, Animal; Emotions; Exploratory Behavior; Fluoxetine; Light; Lithium Chloride; Male; Methylphenidate; Mice; Mice, Inbred C57BL; Restraint, Physical; Stress, Psychological; Swimming | 2012 |
Glycogen synthase kinase-3 levels and phosphorylation undergo large fluctuations in mouse brain during development.
Topics: Age Factors; Animals; Animals, Newborn; Antidepressive Agents; Cerebral Cortex; Female; Fluoxetine; Gene Expression Regulation, Developmental; Glycogen Synthase Kinase 3; Hippocampus; Lithium Chloride; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Signal Transduction | 2012 |
Lithium prevents aberrant NMDA-induced F-actin reorganization in neurons.
Topics: Actins; Animals; Antidepressive Agents; Antipsychotic Agents; Cells, Cultured; Cytoskeleton; Dendrites; Dose-Response Relationship, Drug; Fluoxetine; Glycogen Synthase Kinase 3; Hippocampus; Imipramine; Lithium Chloride; N-Methylaspartate; Neurons; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Time Factors | 2014 |
Subacute administration of fluoxetine prevents short-term brain hypometabolism and reduces brain damage markers induced by the lithium-pilocarpine model of epilepsy in rats.
Topics: Animals; Apoptosis; Astrocytes; Brain; Caspase 3; Disease Models, Animal; Epilepsy; Fluoxetine; Glucose; Hippocampus; Lithium Chloride; Male; Pilocarpine; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Selective Serotonin Reuptake Inhibitors; Survival Analysis | 2015 |
Protein kinase C inhibition rescues manic-like behaviors and hippocampal cell proliferation deficits in the sleep deprivation model of mania.
Topics: Animals; Antidepressive Agents, Second-Generation; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzophenanthridines; Bipolar Disorder; Cell Proliferation; Disease Models, Animal; Fluoxetine; Hippocampus; Lithium Chloride; Male; Piperazines; Prefrontal Cortex; Protein Kinase C; Protein Kinase Inhibitors; Quinolones; Rats, Sprague-Dawley; Sleep Deprivation; Tamoxifen | 2014 |
Fluoxetine ameliorates cartilage degradation in osteoarthritis by inhibiting Wnt/β-catenin signaling.
Topics: Animals; Axin Protein; Cartilage, Articular; Cell Differentiation; Cells, Cultured; Chondrocytes; Chondrogenesis; Disease Models, Animal; Down-Regulation; Fluoxetine; Humans; Lithium Chloride; Matrix Metalloproteinase 13; Osteoarthritis; Phosphorylation; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; SOX9 Transcription Factor; Wnt Signaling Pathway | 2017 |
Effect of early-life stress or fluoxetine exposure on later-life conditioned taste aversion learning in Sprague-Dawley rats.
Topics: Animals; Avoidance Learning; Body Weight; Female; Fluoxetine; Lithium Chloride; Male; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Saccharin; Stress, Psychological; Taste | 2022 |